Table 2.

Tumor measurements (mm) obtained with a digital calliper from the treatment to their sacrifice.

Group	Mouse	Time (Days)/Tumor measurementsa (mm)
		D0			D3			D6			D10
		l	w	t	l	w	t	l	w	t	l	w	t
Control	1–1	9.6	6.6	4.1	14.5	10.0	7.6	18.7	15.1	10.2
	1–2	9.3	7.8	4.8	13.4	8.4	6.1	16.8	12.1	8.6	21.8	17.8	8.7
	1–3	9.4	7.2	4.6	13.6	10.0	7.4
	1–4	8.6	7.4	3.9	10.6	8.4	6.2	15.3	13.3	10.8	17.9	15.3	10.9
	1–5	7.1	7.0	3.8	11.8	9.4	5.9	14.3	13.4	9.2	19.0	15.1	10.0
Laser	2–1	9.6	6.7	4.0	12.2	8.8	5.9	13.5	11.7	9.4	18.8	14.8	10.2
	2–2	9.8	7.1	3.2	11.1	8.4	6.7	16.7	8.2	8.5	20.7	13.3	9.5
	2–3	9.4	6.8	3.6	12.4	11.3	7.5	15.8	12.0	10.8	20.9	16.0	8.9
	2–4	8.5	7.1	4.5	11.3	8.8	6.0	15.8	10.1	9.4	17.2	13.1	10.2
	2–5	8.2	7.7	4.1	13.8	8.5	6.6	16.3	13.0	8.7	19.4	17.5	6.9
NP	3–1	7.8	6.6	4.0	9.5	7.7	6.0	12.4	11.0	7.6	18.6	16.5	8.8
	3–2	7.9	6.4	4.2	8.3	7.7	3.3	12.1	8.4	5.5	20.8	16.0	8.2
	3–3	8.6	6.9	4.7	9.4	8.9	5.1	10.9	9.4	9.8
	3–4	7.2	8.0	4.5	10.0	9.2	5.6	12.8	12.0	7.3	19.6	15.7	9.1
	3–5	8.8	7.0	4.1	7.9	6.9	4.6	11.3	10.4	6.4	17.8	16.6	8.3
Anti-PD1 mAb	5–1	8.5	8.2	3.5	12.1	10.7	8.0	13.2	11.4	8.9	18.0	15.6	9.0
	5–2	9.3	6.2	3.2	10.8	9.9	7.3	11.9	10.5	9.3	18.6	15.9	9.7
	5–3	10.2	7.3	3.5	14.5	13.7	7.0	15.2	13.8	8.2	19.5	15.2	9.7
	5–4	8.4	7.4	5.3	14.7	8.7	6.9	14.8	11.3	7.6	17.5	16.0	10.8
	5–5	9.3	7.6	4.6	13.0	10.7	6.6	16.1	15.2	8.5

^al: length; w: width; t: thickness.